Skip to content

In the BioHarmony Drug Report Database

Tomivosertib

Tomivosertib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against MAP kinase-interacting serine/threonine-protein kinase 2 and MAP kinase-interacting serine/threonine-protein kinase 1. In addition, it is known to target serine/threonine-protein kinase 17A and dual specificity protein kinase CLK4.
Trade Name
Common Name Tomivosertib
Indication
Drug Class Serine/threonine kinase inhibitors
Tomivosertib
Get full access now